Exodus Point Capital Management, LP Ptc Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $1.68 Million - $2.73 Million	68,020 New	68,020 $2.08 Million
Q3 2023 Nov 09, 2023	SELL	$22.41 - $41.99 $932,233 - $1.75 Million	-41,599 Reduced 63.92%	23,483 $526,000
Q2 2023 Aug 10, 2023	BUY	$40.4 - $59.1 $2.63 Million - $3.85 Million	65,082 New	65,082 $2.65 Million
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $1.15 Million - $1.88 Million	-34,254 Reduced 82.1%	7,466 $285,000
Q3 2022 Nov 10, 2022	BUY	$41.85 - $53.85 $1.23 Million - $1.58 Million	29,290 Added 235.64%	41,720 $2.09 Million
Q2 2022 Aug 19, 2022	BUY	$25.6 - $45.23 $318,208 - $562,208	12,430 New	12,430 $498,000
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $352,483 - $426,103	-9,524 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $54,875 - $71,389	1,446 Added 17.9%	9,524 $403,000
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $378,050 - $556,735	8,078 New	8,078 $382,000
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $193,320 - $300,420	-6,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $202,920 - $289,020	6,000 New	6,000 $203,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.